GlassScriptPhysician profile
Mrinal MD Dhar
NPI 1417275256
$1,696.43
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $257 · 2021: $308 · 2022: $83.02 · 2023: $594 · 2024: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $658.72 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $348.12 | 2020-2024 | |
| Medtronic, INC. | $128.18 | 2021-2023 | Interstim |
| Endo Pharmaceuticals INC. | $116.10 | 2022-2023 | Aveed, Xiaflex |
| Abbott Laboratories | $115.00 | 2019 | |
| Boston Scientific Corporation | $56.53 | 2019-2023 | Ams 700 |
| Pfizer INC. | $52.61 | 2020-2021 | |
| Hollister Incorporated | $39.30 | 2021 | |
| Calyxo, INC. | $24.38 | 2024 | Cvac Aspiration System |
| Halozyme INC | $24.10 | 2023 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Urovant Sciences INC | $23.00 | 2021 | |
| Sumitomo Pharma America, INC. | $19.39 | 2024 | Gemtesa |
| Allergan, INC. | $19.23 | 2020 | |
| Coloplast Corp | $18.62 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $17.38 | 2021 | |
| Abc Home Medical Supply, INC. | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mrinal Dhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.